PROPYL-THYRACIL DIN 00010219
Health Canada record
| Active ingredient(s) | PROPYLTHIOURACIL 100 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H03BA02 PROPYLTHIOURACIL |
| Original market date | 31-Dec-1945 |
| Current status date | 07-Apr-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Paladin Pharma Inc. — licence 100234, currently licensed, last inspection rating C (2023-04-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PROPYLTHIOURACIL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02357933 | APO-PROPYLTHIOURACIL | APOTEX INC | Tablet | PROPYLTHIOURACIL 50 MG | Approved |
| 02357941 | APO-PROPYLTHIOURACIL | APOTEX INC | Tablet | PROPYLTHIOURACIL 100 MG | Approved |
| 02521059 | HALYCIL | HALEWOOD CHEMICALS LIMITED | Tablet | PROPYLTHIOURACIL 50 MG | Marketed |
| 02523019 | PROPYLTHIOURACIL TABLETS | PHEBRA CANADA INC | Tablet | PROPYLTHIOURACIL 50 MG | Marketed |
| 02245834 | PMS-PROPYLTHIOURACIL | PHARMASCIENCE INC | Tablet | PROPYLTHIOURACIL 100 MG | Cancelled Pre Market |
| 02245833 | PMS-PROPYLTHIOURACIL | PHARMASCIENCE INC | Tablet | PROPYLTHIOURACIL 50 MG | Cancelled Pre Market |
| 00010200 | PROPYL-THYRACIL | PALADIN PHARMA INC. | Tablet | PROPYLTHIOURACIL 50 MG | Cancelled Post Market |
International API supply for PROPYLTHIOURACIL
2 valid EDQM Certificates of Suitability from 2 holders. 4 active FDA Drug Master Files.
Request a quote for PROPYL-THYRACIL